Milan, Italy

Patrizia Ambrosetti

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Bracco International Bv. Active years: 2002.


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Patrizia Ambrosetti

Introduction

Patrizia Ambrosetti is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel contrast agents. His work has been recognized for its potential to enhance medical imaging techniques.

Latest Patents

Ambrosetti holds a patent for a process titled "Process for the preparation of n,n'-bis[2,3-dihydroxypropyl]-5-[(hydroxyacetyl) methylamino]-2, 4,6-triiodo-1, 3-benzenedi carboxamide." This innovative process is aimed at producing N,N'-bis[2,3-dihydroxypropyl]-5-[(hydroxyacetyl) methylamino]-2,4,6-triiodo-1, 3-benzenedi carboxamide, commonly known as lomeprol. Lomeprol is recognized as a novel non-ionic contrast agent that demonstrates excellent safety and contrast effectiveness.

Career Highlights

Ambrosetti is currently associated with Bracco International Bv, a company known for its advancements in medical imaging and contrast agents. His work at Bracco has been pivotal in the development of innovative solutions that improve diagnostic capabilities in healthcare.

Collaborations

Throughout his career, Ambrosetti has collaborated with esteemed colleagues, including Laura Alessandroni and Maria Argese. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Patrizia Ambrosetti's contributions to the field of pharmaceuticals, particularly through his patent for lomeprol, highlight his role as an influential inventor. His work continues to impact the medical imaging industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…